Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

Jericho Energy Ventures  / Equity Bottom-Up

<ul>
<li>JEV reported Q3 financial results that were in line with our expectations.</li>
<li>Its O&amp;G JV was EBITDA positive again this quarter, reminding us that JEV can effectively redeploy cashflow from the low multiple O&amp;G business to the high multiple hydrogen business.</li>
<li>Production from its O&amp;G JVs was consistent with last quarter, posting positive EBITDA due to the higher commodity prices.</li>
</ul>


JEV reported Q3 financial results that were in line with our expectations.
Its O&amp;G JV was EBITDA positive again this quarter, reminding us that JEV can effectively redeploy cashflow from the low multiple O&amp;G business to the high multiple hydrogen business.
Production from its O&amp;G JVs was consistent with last quarter, posting positive EBITDA due to the higher commodity prices.


JEV: Q3 Financials in Line with Expectations